Description
TBS Stock Solution (10X, pH 7.4) with Phenol Red
| Catalog number: | B2019492 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 125 mL |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | RT |
| Keywords: | TBS Stock Solution (10X, pH 7.4) with Phenol Red |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Glycaemic management in diabetes: old and new approaches Lancet Diabetes Endocrinol. 2022 Jan;10(1):75-84.
- Common buffers, media, and stock solutions Curr Protoc Hum Genet. 2001 May;Appendix 2:Appendix 2D.
- Hammer RD, Fowler D, Sheets LR, Siadimas A, Guo C, Prime MS. Digital Tumor Board Solutions Have Significant Impact on Case Preparation JCO Clin Cancer Inform. 2020 Aug;4:757-768.
- Feuillassier L, Martinez L, Romans P, Engelmann-Sylvestre I, Masanet P, Barthlmy D, Engelmann F. Survival of tissue balls from the coral Pocillopora damicornis L. exposed to cryoprotectant solutions Cryobiology. 2014 Dec;69(3):376-85.
- Agrawal S, Kumari R, Luthra PM. A reliable fluorimetric method to screen the nitric oxide synthase inhibitors in 96 well plate Anal Biochem. 2019 Jul 15;577:42-44.
- Perla V, Nadimi M, Reddy R, Hankins GR, Nimmakayala P, Harris RT, Valluri J, Sirbu C, Reddy UK. Effect of ghost pepper on cell proliferation, apoptosis, senescence and global proteomic profile in human renal adenocarcinoma cells PLoS One. 2018 Oct 31;13(10):e0206183.
- Wang T, Xiang Y, Liu X, Chen W, Hu Y. A novel fluorimetric method for laccase activities measurement using Amplex Red as substrate Talanta. 2017 Jan 1;162:143-150.
- Shevroja E, Cafarelli FP, Guglielmi G, Hans D. DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis Endocrine. 2021 Oct;74(1):20-28.
- Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, Chandana SR, De La Fouchardire C, Dean A, Kiss I, Lee WJ, Goetze TO, Van Cutsem E, Paulson AS, Bekaii-Saab T, Pant S, Hubner RA, Xiao Z, Chen H, Benzaghou F, OReilly EM. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial Lancet. 2023 Oct 7;402(10409):1272-1281.
